ERFONRILIMAB
UNII 9NP50O6YSA

Substance Identification & Data

This profile provides standardized clinical and technical data for Erfonrilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9NP50O6YSA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2367013-69-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

9NP50O6YSA

CAS Registry Number

2367013-69-0

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ERFONRILIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C157632

National Cancer Institute reference terminology for clinical and research data.

INN ID

11617

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Erfonrilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ERFONRILIMAB

Common Names & Synonyms

ERFONRILIMAB [INN]

IMMUNOGLOBULIN G (266-SERINE), BISPECIFIC, ANTI-(HUMAN PROGRAMMED DEATH-LIGAND 1) (HUMAN-CAMELUS BACTRIANUS MONOCLONAL KN046 .GAMMA.-CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GAP) FUSION PROTEIN WITH IMMUNOGLOBULIN G ANTI-(HUMAN CYTOTOXIC T-LYMPHOCYTE-ASSOCIATED PROTEIN 4) (HUMAN-CAMELUS BACTRIANUS MONOCLONAL KN046 .GAMMA.-CHAIN V-D-J REGION) FUSION PROTEIN WITH PEPTIDE LINKER (GS) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C-REGION C-TERMINAL FRAGMENT), DIMER

KN 046 [WHO-DD]